Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1
|
| pubmed:dateCreated |
1988-1-28
|
| pubmed:abstractText |
Methylergometrine, the main metabolite of methysergide, has 40-times greater 5 HT antagonistic potency than methysergide in isolated segments of human temporal artery. It is suggested that methylergometrine is the "active" drug when methysergide is used in migraine prophylaxis, and that the two compounds should be compared in prophylactic trials in migraine.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0031-6970
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
33
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
77-9
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:3691600-Humans,
pubmed-meshheading:3691600-Methylergonovine,
pubmed-meshheading:3691600-Methysergide,
pubmed-meshheading:3691600-Muscle, Smooth, Vascular,
pubmed-meshheading:3691600-Serotonin,
pubmed-meshheading:3691600-Serotonin Antagonists,
pubmed-meshheading:3691600-Temporal Arteries,
pubmed-meshheading:3691600-Vascular Headaches
|
| pubmed:year |
1987
|
| pubmed:articleTitle |
Methylergometrine antagonizes 5 HT in the temporal artery.
|
| pubmed:affiliation |
Department of Neurology, Rigshospitalet, Copenhagen, Denmark.
|
| pubmed:publicationType |
Journal Article,
Comparative Study,
In Vitro,
Research Support, Non-U.S. Gov't
|